Cargando…
Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders
Lipid metabolic diseases have substantial morbidity and mortality rates, posing a significant threat to human health. PPARα, a member of the peroxisome proliferator-activated receptors (PPARs), plays a crucial role in lipid metabolism and immune regulation. Recent studies have increasingly recognize...
Autores principales: | Hu, Ping, Li, Kaiqi, Peng, Xiaoxu, Kan, Yufei, Li, Hao, Zhu, Yanli, Wang, Ziyu, Li, Zhaojian, Liu, Hao-Yu, Cai, Demin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674366/ https://www.ncbi.nlm.nih.gov/pubmed/38004166 http://dx.doi.org/10.3390/nu15224772 |
Ejemplares similares
-
Curcumin derived from medicinal homologous foods: its main signals in immunoregulation of oxidative stress, inflammation, and apoptosis
por: Hu, Ping, et al.
Publicado: (2023) -
Dietary Conjugated Linoleic Acid Modulates the Hepatic Circadian Clock Program via PPARα/REV-ERBα-Mediated Chromatin Modification in Mice
por: Liu, Hao-Yu, et al.
Publicado: (2021) -
Orphan Nuclear Receptor RORγ Modulates the Genome-Wide Binding of the Cholesterol Metabolic Genes during Mycotoxin-Induced Liver Injury
por: Li, Kaiqi, et al.
Publicado: (2021) -
Nuclear Receptor RORα/γ: Exciting Modulators in Metabolic Syndrome and Related Disorders
por: Gu, Haotian, et al.
Publicado: (2022) -
PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension
por: Jiang, Yanli, et al.
Publicado: (2019)